Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Colmenero Velazquez A"'
Autor:
Argentina Colmenero Velazquez, Ignacio Iturrieta-Zuazo, Juan Luis Valdivieso Shephard, Marisa Di Natale, Claudia Rita, Rubén Ballester González, José Luis Castañer Alabau, Israel Nieto Gañán
Publikováno v:
Antibodies, Vol 9, Iss 3, p 41 (2020)
Rituximab (anti-CD20) is commonly used as immunotherapy against B cells, in the context of pre-transplant crossmatches, where the presence of rituximab in the tested sera with donor cells can alter their results both by flow cytometry (FCXM) as compl
Externí odkaz:
https://doaj.org/article/754c89ce74464c0a8feccf03933af342
Autor:
Ignacio Iturrieta-Zuazo, José Luis Castañer Alabau, Argentina Colmenero Velazquez, Claudia Geraldine Rita, Rubén Ballester González, Juan Luis Valdivieso Shephard, Israel Nieto Gañan, Marisa Di Natale
Publikováno v:
Antibodies
Antibodies, Vol 9, Iss 41, p 41 (2020)
Antibodies, Vol 9, Iss 41, p 41 (2020)
Rituximab (anti-CD20) is commonly used as immunotherapy against B cells, in the context of pre-transplant crossmatches, where the presence of rituximab in the tested sera with donor cells can alter their results both by flow cytometry (FCXM) as compl
Autor:
Colmenero Velazquez, Argentina1 (AUTHOR) argentina.colmenero@salud.madrid.org, Iturrieta-Zuazo, Ignacio2 (AUTHOR) ignaciomaria.iturrieta@salud.madrid.org, Valdivieso Shephard, Juan Luis1 (AUTHOR) juanluis.valdivieso@salud.madrid.org, Di Natale, Marisa3 (AUTHOR) marisa.dinatale@salud.madrid.org, Rita, Claudia2 (AUTHOR) claudiageraldine.rita@salud.madrid.org, Ballester González, Rubén2 (AUTHOR) ruben.ballester@salud.madrid.org, Castañer Alabau, José Luis2 (AUTHOR) joseluis.castaner@salud.madrid.org, Nieto Gañán, Israel2 (AUTHOR) israelganan@yahoo.es
Publikováno v:
Antibodies (2073-4468). Sep2020, Vol. 9 Issue 3, p41. 1p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.